Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
Maraj I, Gonzalez MD, Naccarelli GV. Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation. Journal Of Innovations In Cardiac Rhythm Management 2018, 9: 3274-3281. PMID: 32477818, PMCID: PMC7252752, DOI: 10.19102/icrm.2018.090801.Peer-Reviewed Original ResearchAtrial fibrillationStroke preventionCatheter ablationLeft atrial appendage occlusion devicesAtrial appendage occlusion devicesRhythm control strategyOral anticoagulation therapyImportant treatment strategyRisk of strokeAtrial fibrillation ablationCommon sustained arrhythmiaLeft atrial appendageClinical practice todayOral anticoagulationPeriprocedural useAnticoagulation therapySurgical exclusionFibrillation ablationSustained arrhythmiaDrug optionsAtrial appendageTreatment strategiesHigh riskOcclusion devicePatientsA Quarter of a Century Later: What is Dofetilide’s Clinical Role Today?
Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal Of Cardiovascular Pharmacology And Therapeutics 2018, 24: 3-10. PMID: 29940780, DOI: 10.1177/1074248418784288.Peer-Reviewed Original ResearchConceptsAtrial fibrillationAtrial flutterClass III antiarrhythmic agentPost-myocardial infarction patientsAcceptable renal functionAtrioventricular nodal blockadeAcceptable safety profileNormal QT intervalParoxysmal atrial fibrillationReal-world efficacyCreatinine clearanceRenal functionSymptomatic patientsHeart failureAtrial tachycardiaPersistent arrhythmiaSafety profileSinus rhythmAntiarrhythmic agentsInfarction patientsVentricular tachycardiaClinical trialsQT intervalDrug trialsDrug Administration